Media Partners

//Media Partners

Robot Surgeons Coming Soon, to a Future Battlefield Near You

By | March 29th, 2016|Categories: Blog, Blog page|

Technology can bring modern medicine anywhere in the world, if the phone system is working, but humans have to remain in control, says Technion professor Alon Wolf   Breakthrough device helps MRI take better snapshot [...]

Comments Off on Robot Surgeons Coming Soon, to a Future Battlefield Near You

Wave of the future – cutting and pasting genes

By | March 28th, 2016|Categories: Blog, Blog page|

Israeli scientists are being introduced to a new technique to cure some genetic diseases by a Tel Aviv University biologist and geneticist. Anyone familiar with a word-processing program has much experience cutting and pasting for [...]

Comments Off on Wave of the future – cutting and pasting genes

IATI Biomed 2016 Call for abstracts! Deadline extension

By | March 24th, 2016|Categories: Blog, Blog page|

Call for Abstracts  Deadline extended for Oral Company Presentations till April 10 at IATI Biomed 2016 Dear Colleagues, IATI Biomed 2016 is the premier life sciences event providing a meeting place for the healthcare’s industry players [...]

Comments Off on IATI Biomed 2016 Call for abstracts! Deadline extension

BioBlast Pharma Announces Positive Final Results from HOPEMD Phase 2 Open-Label Clinical Study of Trehalose 90mg/mL IV Solution in Oculopharyngeal Muscular Dystrophy (OPMD)

By | March 24th, 2016|Categories: Blog, Blog page|

NEW HAVEN, Conn., March 16, 2016 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced positive results from its HOPEMD Phase 2 six-month open-label clinical study in patients with oculopharyngeal [...]

Comments Off on BioBlast Pharma Announces Positive Final Results from HOPEMD Phase 2 Open-Label Clinical Study of Trehalose 90mg/mL IV Solution in Oculopharyngeal Muscular Dystrophy (OPMD)